Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease
Clinical trial NCT00021723 · TERMINATED
Trial details
- NCT number
- NCT00021723
- Sponsor
- JANSSEN Alzheimer Immunotherapy Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-09-01
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.